MyChesCo on MSN22 天
Windtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failure
Its dual-mechanism of action combines positive inotropic effects achieved through Na+/K+-ATPase inhibition with enhanced ...